How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

Murakami, Naoya; Kuno, Ikumi; Yoshida, Hiroshi; Shiraishi, Kouya; Kato, Tomoyasu; Igaki, Hiroshi

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

Files

rrab130.pdf (182.25 KB)

Authors

Murakami, Naoya

Kuno, Ikumi

Yoshida, Hiroshi

Shiraishi, Kouya

Kato, Tomoyasu

Igaki, Hiroshi

Issue Date

2022-01-18

Type

Article

Language

en_US

Keywords

Low-Risk , Human Papillomavirus (HPV) , De-Intensification , De-Escalation , Uterine Cervical Cancer

Abstract

We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be obtained prior to treatment, and they might classify patients earlier.

Citation

Murakami, N., Kuno, I., Yoshida, H., Shiraishi, K., Kato, T., & Igaki, H. (2022). How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?. Journal of radiation research, 63(2), 312–313. https://doi.org/10.1093/jrr/rrab130

Publisher

Journal of Radiation Research